Neurology Clinical Trials in Washington D.C., DC

As of June 2026, 51 paid clinical trials are recruiting for Neurology in Washington D.C., District of Columbia. Neurology trials investigate disease-modifying therapies for Alzheimer's, Parkinson's, multiple sclerosis, ALS, and stroke recovery alongside symptomatic treatments for epilepsy, migraine, and cognitive decline. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

51 clinical trials for Neurology

·Clear filters·↓ Download CSV

Hand Exoskeleton Training Study

for Stroke

1 location in Washington D.C.

Sponsor: Medstar Health Research Institute

Sex: All·Age: 21+

Code: NCT06786858·Recruiting

Apply to this trial

HEALEY ALS Platform Trial - Master Protocol

for Amyotrophic Lateral Sclerosis

81 locations incl. Phoenix

Sponsor: Merit E. Cudkowicz, MD

Sex: All·Age: 18+

Code: NCT04297683·Phase 2, Phase 3·Recruiting

Apply to this trial

Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder

for Spinal Cord Injuries

2 locations incl. Washington D.C.

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 18 - 75

Code: NCT04350359·Recruiting

Apply to this trial

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for Intracerebral Hemorrhage

187 locations incl. Birmingham

Sponsor: Yale University

Sex: All·Age: 18+

Code: NCT03907046·Phase 3·Recruiting

Apply to this trial

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

for Atrial Fibrillation

51 locations incl. Little Rock

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT04045665·Phase 3·Recruiting

Apply to this trial

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for Generalized Myasthenia Gravis

32 locations incl. Birmingham

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT04202341·Recruiting

Apply to this trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for Autoimmune Disease

Drug: Nivolumab

51 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03816345·Phase 1·Recruiting

Apply to this trial

Longitudinal Early-onset Alzheimer's Disease Study Protocol

for Early Onset Alzheimer Disease

18 locations incl. Sun City

Sponsor: Indiana University

Sex: All·Age: 40 - 64·Accepts healthy volunteers

Code: NCT03507257·Recruiting

Apply to this trial

Late Onset Alzheimer's Disease

for Alzheimer Disease

12 locations incl. Washington D.C.

Sponsor: Columbia University

Sex: All·Age: 55+·Accepts healthy volunteers

Code: NCT05010603·Recruiting

Apply to this trial

Older Breast Cancer Patients: Risk for Cognitive Decline

for Cancer, Breast

1 location in Washington D.C.

Sponsor: Georgetown University

Sex: Female·Age: 60 - 105·Accepts healthy volunteers

Code: NCT03451383·Recruiting

Apply to this trial

DC Longitudinal Study on Aging and Specimen Bank

for Alzheimer Disease

1 location in Washington D.C.

Sponsor: Georgetown University

Sex: All·Age: 45+·Accepts healthy volunteers

Code: NCT03702907·Recruiting

Apply to this trial

Conditions in Neurology (Washington D.C., DC)

Stroke· 14 Alzheimer's disease· 8 Multiple sclerosis· 5 Myasthenia gravis· 5 Dementia· 4 Migraine· 4 Traumatic brain injury (TBI)· 4 Spinal cord injury· 4 Mild cognitive impairment (MCI)· 3 Parkinson's disease· 3 ALS (amyotrophic lateral sclerosis)· 3 Epilepsy· 1 Huntington disease· 1 Multiple system atrophy· 1 Aphasia· 1 Cognitive impairment / decline· 1